Navigation Links
American Chemical Society's Weekly PressPac -- March 19, 2008
Date:3/24/2008

E
http://dx.doi.org/10.1021/ar700120t

CONTACT:
Manuel E. Patarroyo, M.D.
Fundacion Instituto de Immunologia de Columbia
Bogota, Colombia
Phone: 57-1-4815219
Fax: 57-1-4815269
Email: mepatarr@mail.com

ARTICLE #2 FOR IMMEDIATE RELEASE

New triple-threat weapon needed in war between man and microbe
Journal of Natural Products

Mankinds age-old battle against infectious diseases stands to rage on and on, unless scientists develop a new generation of triple-action antibiotics, according to an article scheduled for the March 28 issue of ACS monthly Journal of Natural Products.

In the article, Lester A. Mitscher presents a rather personalized account of the turbulent tug-of-war between microbes and mankind, describing past tactics, lessons learned, and a cautious prediction about the road ahead.

Mitscher notes, for instance, that miracle drugs in the 1940s and 50s failed to live up to expectations. Though penicillin promised an end to infections worldwide in 1941, reports of resistant bacteria appeared only a year later. Significant clinical resistance is now known for virtually all antibiotics in medical use, the article states. Unfortunately, the problem is getting worse since big pharma has largely withdrawn from research directed toward new antibiotic discovery.

The review concludes that microbial resistance is inevitable pending unforeseen breakthroughs. One involves development of new antibiotics that go beyond killing or slowing the growth of disease-causing microbes. Those new medications would contain antimutagenic ingredients that discourage bacteria from mutating into resistant forms. In addition, they would pack immunostimulants that enlist the bodys own immune defense system to fight off an infection. Continued close observation and exploitation
'/>"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert  

1

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Understanding hypertension in African Americans proves elusive
3. Tips from the Journals of the American Society for Microbiology
4. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
5. American College of Medical Genetics responds to new FDA labeling decision for warfarin
6. American Chemical Societys Weekly Press Pac
7. Highlights from the September 2007 Journal of the American Dietetic Association
8. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
9. Report: African, Asian, Latin American farm animals face extinction
10. American Chemical Society calls green chemistry bill a smart step
11. Challenges remain in reintroducing American chestnut
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
American Chemical Society's Weekly PressPac -- March 19, 2008
(Date:5/16/2013)... Abwe, a conservationist working in Cameroon and the manager ... just been awarded the prestigious Whitley award. The ... called "The Green Oscars" because it celebrates the extraordinary ... in developing countries. Abwe was selected for the ... preserve Cameroon,s Ebo Forest and its wildlife inhabitants., HRH ...
(Date:5/16/2013)... The consultancy Frost & Sullivan ... Germany,s largest biometrics manufacturer, DERMALOG ... DERMALOG has been honored yesterday night by ... the category Global Biometrics and Border Control  Customer Value ... Border Control System . One of the decisive factors ...
(Date:5/15/2013)... PHILADELPHIA In the largest clinical trial to date ... BRCA 1/2 carriers with diseases other than breast and ... be effective against advanced pancreatic and prostate cancers. Results ... School of Medicine at the University of Pennsylvania and ... presented during the American Society of Clinical Oncology,s annual ...
Breaking Biology News(10 mins):Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations 2
... cetaceanswhales, dolphins and porpoisesfirst dipped their toes into water, a ... swimming mammals into the larger hoofed animal group. But what ... carnivorous diet, or the loss of their ability to walk? ... resolves this debate using a massive data set of ...
... electron microscopy techniques, a team led by researchers from ... the precise arrangement of chemoreceptorsthe receptors that sense and ... found that this specific architecture is the same throughout ... this is a stable, universal structure that has been ...
... at Cold Spring Harbor Laboratory (CSHL) are among an ... the director of the National Institutes of Health (NIH) ... Professor Partha Mitra, Ph.D., and Assistant Professor Josh ... by the NIH today -- in letters addressed to ...
Cached Biology News:Getting a leg up on whale and dolphin evolution 2Getting a leg up on whale and dolphin evolution 3Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 2Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 3Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 42 neuroscientists from Cold Spring Harbor Laboratory awarded 'transformative' NIH grants 22 neuroscientists from Cold Spring Harbor Laboratory awarded 'transformative' NIH grants 32 neuroscientists from Cold Spring Harbor Laboratory awarded 'transformative' NIH grants 4
(Date:5/17/2013)... Calif. , May 17, 2013  Cellular ... has achieved 50% enrollment of the total projected ... evaluate the safety and preliminary efficacy of the ... therapy for Knee Osteoarthritis (KOA). To date the ... reported. The Phase I open label ...
(Date:5/17/2013)... May 17, 2013  Insero Health, Inc., a company ... epilepsy and related neurological disorders, is today reporting top-line ... compound INS001 in patients with drug-resistant epilepsy.  The data ... Trials (AED) Xll meeting by Dr. Steven ... of Insero,s Scientific Advisory Board.  In this study, INS001 ...
(Date:5/17/2013)... Frederick, MD (PRWEB) May 17, 2013 ... release of ezColony version 4.1, a versatile refinement ... world-class premier software solution, improves its advanced methodical ... animal facilities with ezColony 4.1. The network-based platform ... to conduct effective research. While continuing to emphasize ...
(Date:5/17/2013)... May 17, 2013 Tooth decay is an ... active signs of the disease. The World Health Organization says ... 100% of adults have cavities. What are the long-term effects ... showing a strong connection between the oral bacterial imbalance and ... disease so rampant, yet it is also 100% preventable? Answer: ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... 2008 RiverVest Venture Partners,announced today that it ... Fund II, L.P., with total committed capital of ... was licensed,as a Small Business Investment Company, had ... of leverage from the Small Business Administration., ...
... and JERSEY CITY, New Jersey, April 11, Rosetta ... development of microRNA-based diagnostics and therapeutics, announced,today it ... AACR,conference in San Diego. The posters will include ... they may be applied to develop,objective and standardized ...
... 2008 In the event of an outbreak or ... responsible for virulence or drug resistance is essential to ... analysis of a pathogen genome is time-intensive and likely ... developed a comparative genomics strategy to drastically reduce the ...
Cached Biology Technology:RiverVest Venture Partners(R), a St. Louis-Based Venture Capital Firm Focusing on Life Sciences, Closes on Fund II, Names John P. McKearn, Ph.D., Venture Partner 2RiverVest Venture Partners(R), a St. Louis-Based Venture Capital Firm Focusing on Life Sciences, Closes on Fund II, Names John P. McKearn, Ph.D., Venture Partner 3Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference 2Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference 3Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference 4Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference 5Scientists develop strategy to rapidly describe outbreak strains with next-generation DNA sequencing 2